news article posted prior to Ann providing some perspective on their expectations re the
SP ...
Proteomics awaits US reimbursement ratePredictive diagnostics and bio-analytical services company Proteomics International Laboratories (ASXIQ) remains in a trading halt for an update on the Australian regulatory pathway and reimbursement payment rate in the US for its Promarker D predictive test for diabetic kidney disease.The payment rate is set by the American Medical Association (AMA) pricing review and is what labs can charge patients.“This is very big news and will tell us what the pricing is and we’ve modelled $US150 per test so if it’s that it will be terrific and give us our $1.66 price target,” he says.“If it’s higher than that, that is an upside to our valuation – and conversely if it’s lower – but we believe we were very conservative when setting our price target assumptions so we are confident it will be $150 or more.”
https://www.townsvillebulletin.com.au/business/*/scopos-powerplays-matter-of-death-and-life-ramsay-cops-credit-downgrade/news-story/e288b3928d29e76796a45ae7bf2088ba
Reimbursement of $155 give them a fair value of $1.66...so a $390 payment is double therefore $3.20 ?
$390 opens up a significant number of diabetics for affordable testing by Sonic...imo
glta
news article posted prior to Ann providing some perspective on...
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
70.0¢ |
Change
0.010(1.45%) |
Mkt cap ! $91.70M | |||
| Open | High | Low | Value | Volume |
| 69.0¢ | 70.5¢ | 68.5¢ | $29.16K | 41.85K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12777 | 70.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 71.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 15.12pm 08/11/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |